Search - tctmd.com

Displaying 241 - 260 of 1205

Sort: Relevancy | Date

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

L.A. McKeown

October 24, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

News Daily News

Cardiothoracic Surgeon Domenico Pagano Dies

Michael O'Riordan

October 13, 2022

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

Caitlin E. Cox

October 11, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

INOCA Exerts Heavy Toll on Daily Life: Survey

Caitlin E. Cox

September 28, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2022

TCT 198: Differential Improvement in Angina and Health-related Quality of Life after Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease

Presenter: Takuya Mizukami

September 18, 2022

Presentation TCT 2022

TCT 39: Mobile application improves quality of care for patients with STEMI

Presenter: Annapoorna Kini

September 17, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Advertisement

Many STEMI Patients Not Treated Within National Time Goals

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Cardiothoracic Surgeon Domenico Pagano Dies

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

October 2022 News Roundup

INOCA Exerts Heavy Toll on Daily Life: Survey

Most Patient-Reported Outcome Measures in CVD Fall Short

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

TCT 198: Differential Improvement in Angina and Health-related Quality of Life after Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease

TCT 39: Mobile application improves quality of care for patients with STEMI

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content